Abbott Laboratories vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.1
Buy
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
ABT
Analysts see 31% upside to $118.64 consensus target.
⚠ earnings contracting 20% year-over-year.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $118.64 (+31.1%)
25 analysts
HOLD
Target $29.00 (+8.6%)
27 analysts
Fundamentals
ABT
PFE
25.3×
Trailing P/E
19.6×
14.9×
Forward P/E
9.5×
13.9%
Profit Margin
12.4%
56.5%
Gross Margin
75.8%
—
ROE
8.9%
7.8%
Revenue Growth
-1.2%
-19.7%
Earnings Growth
—
0.78
Beta
0.39
—
Price / Book
—
$157.2B
Market Cap
$152.0B
$90 – $139
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.